Gazyvaro

obinutuzumab · Roche Registration GmbH

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Gazyvaro, covering 2014-05-23 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma [Phase 2]